Whetstone Capital Advisors LLC Cuts Stock Position in Phreesia, Inc. $PHR

Whetstone Capital Advisors LLC cut its stake in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 34.0% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 629,752 shares of the company's stock after selling 324,176 shares during the period. Phreesia comprises about 1.7% of Whetstone Capital Advisors LLC's holdings, making the stock its 16th biggest holding. Whetstone Capital Advisors LLC owned 1.01% of Phreesia worth $6,480,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Royal Bank of Canada increased its stake in shares of Phreesia by 208.8% during the first quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock worth $617,000 after purchasing an additional 16,309 shares in the last quarter. AQR Capital Management LLC lifted its stake in Phreesia by 471.2% in the 1st quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock valued at $4,090,000 after buying an additional 132,015 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Phreesia by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock worth $1,599,000 after buying an additional 2,158 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in Phreesia by 262.7% in the 1st quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock worth $395,000 after buying an additional 11,181 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Phreesia by 0.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after buying an additional 2,402 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on PHR. Royal Bank Of Canada reissued an "outperform" rating and set a $19.00 target price on shares of Phreesia in a report on Thursday, September 3rd. Citigroup reaffirmed a "market perform" rating on shares of Phreesia in a research note on Friday, September 4th. Weiss Ratings downgraded Phreesia from a "sell (d+)" rating to a "sell (d)" rating in a research note on Friday, September 4th. DA Davidson decreased their price objective on Phreesia from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Friday, September 4th. Finally, Raymond James Financial cut shares of Phreesia from an "outperform" rating to a "market perform" rating in a research note on Tuesday. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $14.00.

Phreesia Trading Up 1.3%

Shares of Phreesia stock opened at $10.35 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.76 and a quick ratio of 1.76. The stock's 50 day simple moving average is $11.26 and its 200-day simple moving average is $10.43. The stock has a market cap of $642.55 million, a P/E ratio of 60.90 and a beta of 0.86. Phreesia, Inc. has a 1-year low of $7.77 and a 1-year high of $27.00.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The company had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. During the same period in the prior year, the business posted $0.01 EPS. Phreesia's revenue for the quarter was up 10.4% compared to the same quarter last year. Analysts predict that Phreesia, Inc. will post 0.38 EPS for the current fiscal year.

About Phreesia

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.